v3.26.1
Goodwill and Intangible Assets (Tables)
 6 Months Ended
Mar. 31, 2026
Goodwill and Intangible Assets Disclosure [Abstract]  
Schedule of Goodwill [Table Text Block]
The following table sets forth the changes in the carrying amount of goodwill by operating and reportable segment since September 30, 2025 (in thousands).
Sample
Management
Solutions		MultiomicsTotal
Balance - September 30, 2025$505,635 $196,760 $702,395 
Acquisition of UK Biocentre5,116 — 5,116 
Impairment(36,647)(112,436)(149,083)
Currency translation adjustments(5,358)— (5,358)
Balance - March 31, 2026$468,746 $84,324 $553,070 
Accumulated goodwill impairments, March 31, 2026$(36,647)(112,436)$(149,083)
Schedule of Finite-Lived Intangible Assets [Table Text Block]
The components of the Company’s identifiable intangible assets as of March 31, 2026 and September 30, 2025 are as follows (in thousands):
March 31, 2026September 30, 2025
CostAccumulated
Amortization		Net Book
Value		CostAccumulated
Amortization		Net Book
Value
Patents$1,220 $1,220 $— $1,220 $1,220 $— 
Completed technology110,967 67,355 43,612 111,501 63,408 48,093 
Trademarks and trade names1,740 339 1,401 727 293 434 
Customer relationships249,155 202,735 46,420 248,846 195,559 53,287 
Total$363,082 $271,649 $91,433 $362,294 $260,480 $101,814 
Schedule of Finite-Lived Intangible Assets, Future Amortization Expense [Table Text Block]
Estimated future amortization expense for the intangible assets as of March 31, 2026 is as follows for the remainder of fiscal year 2026, the subsequent four fiscal years and thereafter (in thousands):
Remainder of fiscal year 2026$11,316 
202717,978 
202815,108 
202912,480 
203010,904 
Thereafter23,647 
Total91,433